Specialized Biostatistics Biostatistical Consulting Inc. (BCI) is a specialized biostatistics and programming services firm serving biotech, pharma, and medical device clients, with deep expertise in clinical trial design, analysis, and regulatory submissions, presenting a clear value proposition for ongoing and future trial support.

Clinical Trial Focus Most work revolves around design and analysis of clinical trials across multiple phases, offering a broad suite from sample size calculations to integrated efficacy and safety summaries, which aligns well with sponsor needs during protocol development, IND/IDE submissions, and FDA interactions.

Regulatory Experience Experience with INDs, NDAs, BLAs, IDEs, PMAs, and 510(k)s positions BCI for regulatory-compliant analytics and submissions, suggesting cross-selling opportunities for regulatory reporting, DMC support, and FDA/EMA interactions.

Boutique Scale Advantage With 11-50 employees and a senior-expert team, BCI can offer responsive, bespoke statistical consulting and allowed tactical support that larger firms may under-serve, presenting a compelling option for fast-moving projects or flexible resource augmentation.

Growth Fit with Outsourcing Revenue in the lower mid-range of $10M-$25M indicates room to scale through expanded trial engagements, additional therapeutic areas, and extended services (data monitoring, integrated summaries, CRO-like support) to mid-to-large biotech and pharma customers seeking cost-effective, high-touch statistical partnerships.